Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
The device is believed to be the first demonstration of aerosol jet 3D printing to produce an implantable, stretchable sensing system for wireless monitoring.
Expanded indication allows opportunity to provide longer duration of support for critically ill patients and a longer period of assessment of heart recovery.
Trials to examine efficacy of treatment with Pericardial TAVR System with the Everdur transcatheter heart valve and Coronatix Transfemoral Delivery Catheter.